Effects of sweet bee venom pharmacopuncture treatment for chemotherapy-induced peripheral neuropathy: A case series

Integrative Cancer Therapies

Volumn 11, Issue 2, 2012, Pages 166-171

  Park, Jae Woo ^a   Jeon, Ju Hyun ^a   Yoon, Jeungwon ^a   Jung, Tae Young ^a   Kwon, Ki Rok ^b   Cho, Chong Kwan ^a   Lee, Yeon Weol ^a   Sagar, Stephen ^c   Wong, Raimond ^c   Yoo, Hwa Seung ^a  

^a Daejeon University   (South Korea)

^b Pharmacopuncture Medical Research Institute   (South Korea)

^c MCMASTER UNIVERSITY   (Canada)

Author keywords

chemotherapy induced peripheral neuropathy; Korean medicine; melittin; safety; sweet bee venom pharmacopuncture; VAS

Indexed keywords

ANTINEOPLASTIC AGENT; BEE VENOM; CARBOPLATIN; GABAPENTIN; MELITTIN; PACLITAXEL; PARACETAMOL; TRAMADOL;

ACUPUNCTURE; ADULT; ANAPHYLAXIS; ARTICLE; CANCER PATIENT; CHEMOTHERAPY INDUCED PERIPHERAL NEUROPATHY; CLINICAL ARTICLE; DISEASE CONTROL; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; FUNCTIONAL ASSESSMENT; FUNCTIONAL ASSESSMENT OF CANCER THERAPY GENERAL; HUMAN; INJECTION SITE PAIN; KOREA; OVARY CANCER; PAIN ASSESSMENT; PERIPHERAL NEUROPATHY; PHARMACOPUNCTURE; PRIORITY JOURNAL; RATING SCALE; SYMPTOMATOLOGY; TREATMENT OUTCOME; TREATMENT RESPONSE; UTERINE CERVIX CANCER; VISUAL ANALOG SCALE;

ACUPUNCTURE THERAPY; ANTINEOPLASTIC AGENTS; BEE VENOMS; FEMALE; HUMANS; MELITTEN; MIDDLE AGED; NEOPLASMS; PAIN MEASUREMENT; PERIPHERAL NERVOUS SYSTEM DISEASES; PROSPECTIVE STUDIES; REPUBLIC OF KOREA;

EID: 84862020700     PISSN: 15347354     EISSN: 1552695X     Source Type: Journal    
DOI: 10.1177/1534735411413265     Document Type: Article

References (32)

1. Hausheer FH, Schilsky RL, Bain S, Berghorn EJ, Lieberman F. diagnosis, management, and evaluation of chemotherapy-induced peripheral neuropathy. Semin Oncol. 2006;33:15-49. (Pubitemid 43214485)
2. Chaudhry V, Rowinsky EK, Sartorius SE, Donehower RC, Cornblath DR. Peripheral neuropathy from taxol and cisplatin combination chemotherapy: clinical and electrophysiological studies. Ann Neurol. 1994;35:304-311. (Pubitemid 24089653)
3. Cavaletti G, Zanna C. Current status and future prospects for the treatment of chemotherapy-induced peripheral neurotoxicity. Eur J Cancer. 2002;38:1832-1837. (Pubitemid 35247468)
4. Wong R, Sagar S. Acupuncture treatment for chemotherapy-induced peripheral neuropathy - A case series. Acupunct Med. 2006;24:87-91. (Pubitemid 44048896)
5. Hammack JE, Michalak JC, Loprinzi CL, et al. Phase III evaluation of nortriptyline for alleviation of symptoms of cis-platinum-induced peripheral neuropathy. Pain. 2002;98:v 195-203.
6. Munstedt K, Hackethal A, Schmidt K. Bee venom therapy, bee venom acupuncture of apipunture: what is the evidence behind the various health claims? Am Bee J. 2005;145:665-668. (Pubitemid 41095915)
7. Kim YS, Jun H, Chae Y, et al. The practice of Korean medicine: an overview of clinical trials in acupuncture. Evid Based Complement Alternat Med. 2005;2:325-352. (Pubitemid 41253346)
8. Lee JD, Park HJ, Chae Y, Lim S. An overview of bee venom acupuncture in the treatment of arthritis. Evid Based Complement Alternat Med. 2005;2:79-84. (Pubitemid 41399517)
9. Doh WS, Jang JH, Kim KH, Yoon JW, Kim KS. Effects of bee venom therapy on inflammatory edema on knees of rats. J Kor Acupunct Mox Soc. 1995;12:211-220.
10. Lee JH, Kwon YB, Han HJ, et al. Bee venom pretreatment has both an antinociceptive and anti-inflammatory effect on carageenan-induced inflammation. J Vet Med Sci. 2001;63:251-259.
11. Kwon GR. Clinical study on treatment of rheumatoid arthritis by bee venom therapy. Proc Congress Kor Med. 1998: 130-131.
12. Wang OH, Ahn KB, Lim JK, Jang HS. Clinical study on effectiveness of bee venom therapy on degenerative knee arthritis. J Kor Acupunct Mox Soc. 2001;18:35-47.
13. Park HJ, Lee SH, Son DJ, et al. Antiarthritic effect of bee venom: inhibition of inflammation mediator generation by suppression of NF-kappaB through interaction with the p50 subunit. Arthritis Rheum. 2004;50:3504-3515.
14. Choi YC, Kwon KR, Choi SH. Purification of peptide components including melittin from bee venom using gel filtration chromatography and propionic acid/urea polyacrylamide gel electrophoresis. J Korean Pharmacoacupunct Inst. 2006;9:105-112.
15. Kwon KR, Choi SH, Cha BC. Component analysis of sweet BV and clinical trial on antibody titer and allergic reactions. J Korean Pharmacoacupunct Inst. 2006;9:79-86.
16. Lee JS, Lee JY, Kwon KR, Lee HC. A study on allergic response between bee venom and sweet bee venom pharmacopunture. J Korean Pharmacoacupunct Inst. 2006;9:61-77.
17. Yoo HS, Kim JS. The effect of sweet bee venom pharmacopuncture (SBVP) on cancer-related pain: a randomized controlled trial and double blinded pilot study. J Korean Pharmacoacupunct Inst. 2008;11:21-29.
18. Korean Pharmacopuncture Institute Academic Committee. Pharmacopuncturology. Seoul, Korea: Elsevier; 2008: 167-199.
19. Kang KS, Kwon KR. Experimental studies of validation and stability of sweet bee venom using HPLC. J Korean Pharmacoacupunct Inst. 2009;12:33-49.
20. MacPherson H, Altman DG, Hammerschlag R, et al. Revised STandards for Reporting Interventions in Clinical Trials of Acupuncture (STRICTA): extending the CONSORT statement. PLoS Med. 2010;7: e1000261.
21. Moon DO, Park SY, Lee KJ, et al. Bee venom and melittin reduce proinflammatory mediators in lipopolysaccharide-stimulated BV2 microglia. Int Immunopharmacol. 2007;7:1092-1101.
22. Kwon KR. Pharmacopuncturology. Seoul, Korea: Elsevier Korea; 2008.
23. Carlsson AM. Assessment of chronic pain. I. Aspects of the reliability and validity of the visual analogue scale. Pain. 1983;16:87-101. (Pubitemid 13084857)
24. Miller AB, Hoogstraten B, Staquet M, Winkler A. Reporting results of cancer treatment. Cancer. 1981;47:207-214. (Pubitemid 11167383)
25. Cella DF, Tulsky DS, Gray G, et al. The Functional Assessment of Cancer Therapy Scale: development and validation of the general measure. J Clin Oncol. 1993;11:570-579. (Pubitemid 23071057)
26. Cella D. Manual of the Functional Assessment of Chronic Illness Therapy (FACIT) scales. Evanston, IL: Evanston Northwestern Healthcare and Northwestern University at Evanston; 1997.
27. Ocean AJ, Vahdat LT. Chemotherapy-induced peripheralneuropathy: pathogenesis and emerging therapies. Support Care Cancer. 2004;12:619-625. (Pubitemid 39280311)
28. Verstappen CC, Heimans JJ, Hoekman K, Postma TJ. Neurotoxic complications of chemotherapy in patients with cancer: clinical signs and optimal management. Drugs. 2003;63:1549-1563. (Pubitemid 36976138)
29. Kim YJ, Lim CS, Kwon KR. Study of single dose test of sweet bee venom in rats. J Korean Pharmacoacupunct Inst. 2009;12:5-31.
30. Roh DH, Kwon YB, Kim HW, et al. Acupoint stimulation with diluted bee venom (apipuncture) alleviates thermal hyperalgesia in a rodent neuropathic pain model: involvement of spinal alpha2-adrenoceptors. J Pain. 2004;5: 297-303.
31. Koyama N, Iwashita N. Melittin-induced neurogenic inflammation is increased through activation of peripheral glutamate receptors. Pain Res. 2007;22:35-41.
32. Chaudhry V, Chaudhry M, Crawford TO, Simmons-O'Brien E, Griffin JW. Toxic neuropathy in patients with pre-existing neuropathy. Neurology. 2003;60:337-340. (Pubitemid 36152036)